Complexities of CYP2D6 gene analysis and interpretation

Area of Science:

• Pharmacogenomics
• Molecular Biology
• Clinical Pharmacology

Background:

• Cytochrome P450 2D6 (CYP2D6) is vital for metabolizing approximately 25% of clinical drugs.
• CYP2D6 activity exhibits significant inter-individual variability, from poor to ultrarapid metabolizers.
• Genetic polymorphisms in the CYP2D6 gene are a primary driver of this metabolic variability.

Purpose of the Study:

• To review the complexities of CYP2D6 genetic variation and genotype analysis.
• To highlight the importance of understanding CYP2D6 polymorphisms for clinical applications.
• To bridge the gap between CYP2D6 genotype and phenotype for improved drug therapy.

Main Methods:

• Comprehensive literature review on CYP2D6 gene variations.
• Analysis of allelic variants, including SNPs, indels, CNVs, and rearrangements.
• Examination of ethnic variations in allele frequencies.

Main Results:

• Over 100 CYP2D6 variants and subvariants have been identified.
• Allele frequencies differ significantly across ethnic groups.
• CYP2D6 gene locus complexity includes variations and rearrangements with CYP2D7.

Conclusions:

• CYP2D6 genetic variability profoundly influences drug efficacy and safety.
• Pharmacogenetic testing can identify individuals at risk for adverse events or treatment failure.
• Accurate interpretation of CYP2D6 genotype is essential for personalized drug therapy.